News for Genmab A/S (GNMSF)

**media[557236]**

**media[553867]**

**media[553859]**

We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other stocks...

**media[550155]**

We recently published a list of 12 Best Growth Stocks to Invest In According to Analysts.

**media[544708]**

Genmab A/S (GMAB) Q4 2024 Earnings Conference Call February 12, 2025 12:00 PM ETCompany ParticipantsJan van de Winkel - CEOBrad Bailey - EVP and Chief...

The following slide deck was published by Genmab A/S in conjunction with their 2024 Q4 earnings call.

Feb 12, 2025 / 05:00PM GMTOperator Hello, and welcome to the Genmab full year 2024 financial results conference call. As a reminder, this conference call is bei

**media[539166]**

PR NewswireVALBY, Denmark, Feb. 12, 2025 The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatmen

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other healthcare...

We recently published a list of 12 High Growth International Stocks to Invest in Now.

**media[505195]**

Genmab A/S shares dropped 25% despite positive data and acquisition of ProfoundBio. Click for my updated look at GMAB stock prospects.

**media[486777]**

**media[486513]**

**media[486509]**